The Role of Adenosine In the Regulation of Cerebral Blood Flow Metabolic regulation of cerebral blood flow (CBF) and cerebral vascular resistance (CVR) is a widely accepted hypothesis, but the mechanism(s) whereby brain regulates its own blood flow remains obscure. Several factors, such as H+, CO 2 , lactate, and K+ have been proposed as the chemical mod ulators linking CBF to metabolism. For a substance to be considered as a mediator of metabolic regula tion of CBF, it must meet certain criteria:
1. It must be a potent dilator of cerebral resis tance vessels.
2. The brain tissue must be capable of producing the mediator during conditions in which CBF and metabolism are altered.
3. The concentrations reached in the perivascu lar regions must be sufficient to elicit the degree of vasodilation observed with metabolic stimulation. 4. The time course and magnitude of the increase in the vasodilator substance must parallel the meta bolically induced increase in CBF.
5. Potentiators of the mediator should cause an increase in CBF, whereas inhibitors of the mediator should cause a decrease in CBF.
At present, no previously proposed mediator ful fills all of these criteria; in some cases there is con flicting information, whereas in others, there are in sufficient data available. For example, a decrease in pH was previously assumed to be the stimulus for the increase in CBF during hypoxia, but extracel lular pH has been found to be alkalotic during the initial period of hypoxia (Astrup et al. , 1978) . Potas sium, a potent vasodilator (Kuschinsky et aI. , 1972) , is also considered to play a role in CBF regulation during hypoxia. However, the observed increases in potassium are minimal during the initial periods of hypoxia and, therefore, unlikely to account for the large increase in CBF (Astrup et aI. , 1978) . In contrast, K+ rapidly rises with bicuculline seizures (Astrup et aI. , 1978) . Under similar circumstances, pH rises rapidly and transiently in rats (Astrup et aI., 1978) , but in cats it is reported to fall . During sustained hypotension, despite a decrease in CVR, perivascular pH and K+ are unchanged . Thus, under different conditions, no consistent changes 239 have been observed in previously proposed mediators. Conceivably, more than one metabolic factor may be involved in CBF regulation under different conditions (Rubio et aI. , 1975) , and the rel ative contributions to vasodilation may vary tem porally within the duration of the stimulus.
A recent addition to this list of possible chemical factors linking blood flow and metabolism is the purine nucleoside, adenosine, which has been pro posed as a metabolic regulator of coronary blood flow (Berne, 1963) . In the heart, adenosine is a coronary vasodilator (Wolf and Berne, 1956) and is increased in myocardial work (Foley et aI. , 1978; Miller et aI. , 1979; Watkinson et aI. , 1979; Bacchus et aI. , 1981) . Moreover, Thompson et ai. (1980) re cently demonstrated changes in myocardial adenosine concentrations within a single cardiac cycle (high in systole, low in diastole), indicating a rapid metabolism of adenosine.
In brain, adenosine has been proposed as a reg ulator of CBF (Berne et aI. , 1974) , as well as a mod ulator of synaptic transmission (McIlwain, 1973) . In the latter role, adenosine has many functions; it has been suggested as acting as both a presynaptic (Shepherd, 1978) and postsynaptic (Henon et aI. , 1981) inhibitor and has been shown to depress the excitability of cortical neurons (Phillis et aI., 1975) . We have chosen to concentrate on the role of adenosine as a regulator of CBF but recognize that other proposed functions of adenosine in brain may be interrelated. For example, with moderate sys temic hypotension, increases in brain adenosine concentrations (Winn et aI. , 1980b ) may be of sig nificant magnitude not only to increase CBF, but also to depress the electroencephalograph (EEG) and evoked potentials. In addition to the proposed CBF and neural functions, adenosine also has sig nificant metabolic actions, serving as a potent stimulant of cyclic AMP production in brain (Sattin and Rail, 1970) .
Adenosine is a likely candidate for the chemical link between CBF and metabolism for the following reasons:
1. Adenosine is a dilator of pial vessels in the dog (Berne et aI. , 1974) and in the cat (Wahl and Kuschin-sky, 1976; Gregory et aI., 1980) . Human cerebral vessels also dilate when extracellular concentra tions of adenosine are increased in vitro (Hardebo and Edvinsson, 1979) and in vivo (personal obser vations). After topical micropipette application of adenosine, Wahl and Kuschinsky (1976) found a sigmoid-shaped dose-response curve for feline pial (>50 /Lm) vessels, with a minimal and maximal di lation occurring between 10-9 and 10-3 M, respec tively, and the inflection point at 10-6 M. In the dog , smaller vessels «50 /Lm) showed a greater dilation to topical adenosine than larger vessels. After alteration in CSF concentration of the adenosine analog, 2-chloroadenosine, sig nificant increases in regional cerebral blood flow have also been observed (Winn et aI., 1981b) . As suming that adenosine exists predominantly in the extracellular space, as studies from other tissues would suggest (Schrader et aI., 1972; Mustafa et aI., 1975) , then the concentrations observed in rapidly frozen brain tissue (Schultz and Lowenstein, 1978; Winn et aI., 1979; 1980b ,c, 1981a are in the vasoactive range described by Wahl and Kuschin sky (1976) .
Whereas topical application causes a significant increase in pial vessel diameter and CBF, intraca rotid infusion of adenosine in the dog does not affect CBF (Berne et aI., 1974) . Moreover, little radioac tivity is found in CSF or brain tissue after intrave nous or intracarotid infu sion of [14C] adenosine (Berne et aI., 1974; Rubio et aI., 1978) , and simi larly, little radioactivity is found in venous blood after convexity-cisternal infusions of [14C]adenosine (Winn et aI., 1980a) . Therefore, a relative blood brain and CSF-blood barrier exists for adenosine (Berne et aI., 1974; Cornforde and Oldendorf, 1975) , and unlike blood, CSF does not contain enzymes that metabolize adenosine or its degradative prod ucts (Winn et aI., 1980a) . Consequently, changes in brain adenosine reflect cerebral, not systemic, events. Therefore, adenosine is, in all respects, a local metabolite and, hence, an ideal candidate for the local regulation of CBF.
2. Adenosine is rapidly increased in brain during profound ischemia (Winn et aI., 1979) . Five seconds after mean arterial blood pressure (MABP) de creased to 0 mm Hg from normal (> 100 mm Hg) levels, adenosine concentrations increased 2.5-fold (Winn et al., 1979) . During similar periods of short-lasting ischemia and hypotension, pial vessels dilated (Kontos et aI., 1978) . The time course of the
increase in adenosine levels in response to isch emia, therefore, occurs with sufficient rapidity to account for the vascular response observed during ischemia.
3. During sustained hypotension in rats, brain adenosine levels were increased even within the autoregulatory blood pressure range (Winn et aI., 1980b) . When MABP was decreased from 135 to 70 mm Hg, adenosine levels in brain were doubled, but no changes were observed between 135 and 107 mm Hg. Profound increases were noted when MABP decreased to 45 mm Hg (Winn et aI., 198Ob) . Re cently, Bockman et ai. (1981) noted an increase in CSF concentration of adenosine when MABP was decreased from 114 to 70 mm Hg.
4. With sustained hypoxia and use of a rapid brain sampling technique, Rubio et ai. (1975) noted an increase in brain adenosine levels, but Rehn crona et al. (1978) , using a slow method of freez ing brain, failed to confirm the inverse relationship between brain levels of adenosine and Pao2• How ever, subsequent work (Winn et aI., 1981a) revealed that rapid freezing methods are necessary to sample rat brain when determining changes in brain adenosine levels under conditions in which CBF is elevated. Adenosine was also increased during hypocarbia (Paco2 < 20 mm Hg), presumably due to tissue hypoxia at these levels of P aC02 (Rubio et aI., 1975; Winn et aI., 1981a) .
With the onset of hypoxia, CBF was increased 2-fold within 30 s (Astrup et aI., 1978) ; and during similar brief periods of hypoxia (30 s), adenosine increased 6-fold (Winn et aI., 1981a) . Therefore, adenosine appears to be a relatively sensitive index of cerebral hypoxia, and the changes in CVR and brain adenosine levels during hypoxia are tempor ally related.
5. During bicuculline-induced seizures in rats, adenosine concentrations increased 6-fold during the first 10 s and remained elevated for at least 2 min (Winn et aI., 1980c) . With bicuculline seizures, CBF increased 8-to 9-fold (Meldrum and Nilsson, 1976) , and the changes in CBF paralleled the changes in adenosine (Winn et aI., 198Oc) . Similar increments in adenosine levels were present 20 min after induc tion of seizures in cats (Schrader et aI., 1980) . In addition, electrically induced convulsions resulted in large increases in cerebral adenosine concentra tions in rats (Schultz and Lowenstein, 1978) and constant low-voltage stimulation in vivo (Rubio et aI., 1975) or in brain slices (Pull and McIlwain, 1972) caused an increase in brain adenosine levels. Adenosine concentrations in brain are therefore in creased not only when oxygen delivery is decreased (i. e. , ischemia and sustained hypotension), but also when oxygen demand is increased (i. e. , seizures).
6. Although the data cited above suggest that adenosine may be involved in CBF regulation, it is only circumstantial. However, recent work using potentiators and inhibitors of adenosine contributes more direct support for the adenosine hypothesis. For example, experiments in the rabbit have shown an increase in CBF during intracarotid infusions of dipyridamole (Heistad and Marcus, 1980) . Di pyridamole is an inhibitor of cellular uptake of adenosine and should cause an increase in ex tracellular concentrations that could lead to an in crease in CBF. In another recent study, Kontos and Wei (1981) placed adenosine deaminase in the CSF under cranial windows in cats and observed a significant reduction in hypoxia-induced vasodila tion of the pial vessels. Adenosine deaminase is a specific catalyst for the breakdown of adenosine to inosine and in itself did not have a nonspecific ac tion on pial vessels during normoxia.
Whereas it has now been demonstrated that changes in adenosine occur in the brain when CVR is decreased, the factors that control and regulate the production of adenosine are unclear. Adenosine may be formed by dephosphorylation of 5' -AMP by 5' -nucleotidase. This enzyme has been located on the glial membrane of the astrocytic footplates which invest intracerebral vessels (Kreutzberg et aI. , 1978) . Thus, high concentrations of adenosine conceivably could exist in the perivascular space. 5' -Nucleotidase is greatly suppressed in vivo and is inhibited by many factors, including ADP and ATP (lpata, 1968; Burger and Lowenstein, 1975) , whereas Mg2+ reverses the inhibition by ADP and ATP (Sullivan and Alpers, 1971; Kluge et aI. , 1972) . In addition to the effects of adenine nucleotide and magnesium levels, 5'-nucleotidase activity is inhib ited by phosphocreatine, an inhibition that is re versed by free Mg 2 + (Rubio et aI. , 1979) . Hence, rapid decreases in phosphocreatine, combined with release of free Mg 2 + (chelated to ATP), could cause an increase in 5'-nucleotidase activity. An inverse relationship exists for adenosine and phosphocre atine in ischemia (Winn et aI. , 1979) and seizures (Winn et aI. , 198Oc) .
Although most adenosine probably takes origin from cellular AMP, it could arise from the break-down of extracellular ATP (released with neural transmitters), since 5' -nucleotidase is an ectoen zyme. In addition, adenosine may also be formed by the metabolism of S -adenosylhomocysteine. The latter compound is formed from S-adenosylmethi onine, which is the major methyl donor in the brain (Axelrod, 1971) . Transmethylation reactions, such as occur with neural transmitter metabolism, could therefore result in the obligatory production of adenosine.
How adenosine elicits relaxation of vascular smooth muscle is unclear. One possible mechanism is via the production of an increase in vascular smooth muscle cyclic AMP, which has been re ported to be associated with vascular smooth mus cle relaxation (Triner et aI., 1971) . As indicated ear lier, in brain slices, adenosine elicits a significant increase in cyclic AMP (Sattin and RaIl, 1970) ; but in strips of media of hog carotid arteries or dog coronary arteries, an increase in cyclic AMP could be produced only at pharmacological concentra tions of adenosine (Herlihy et aI. , 1976) . Another possibility based on indirect evidence is that adenosine blocks calcium uptake by the vascular smooth muscle cells or that it interferes with cal cium utilization in the contractile machinery of the tissue (DeGubareff and Sleator, 1965; Schrader et aI. , 1974; Belardinelli et aI. , 1979; Fenton et aI. , 1980) . However, direct proof of this mechanism is lacking.
Despite increasing evidence supporting the role of adenosine as a regulator of CBF, the data must be interpreted with caution for several reasons. The concentrations for whole brain discussed above are based on the assumption that adenosine exists solely in the extracellular space. Recent work in heart (Olsson et aI. , 1979) , liver (Belloni et aI., 1980) , and brain (Schatz et aI. , 1978) suggests some com ponent of the adenosine pool is not extracellular. Thus, the concentrations of adenosine calculated to exist in the extracellular space may be considerably lower than those previously calculated. However, whole brain adenosine concentrations do not ac count for the differences in tissue concentrations, which may occur in brain due to the perivascular location of 5' -nucleotidase (Kreutzberg et aI. , 1978) . Assuming that adenosine is produced primarily by the actions of 5'-nucleotidase, the adenosine con centrations would rise more rapidly and dramat ically in the perivascular space than would be suggested by whole brain measurements. This in-ability to measure perivascular concentration of adenosine may account for the failure to observe increases in brain concentrations of adenosine, ex cept at the extremes of the autoregulatory blood pressure range. With the development of more sen sitive analytical techniques and possibly an adenosine electrode, the measurement of perivas cular concentrations may be achieved.
Any proposed role for adenosine in CBF regula tion must also take into consideration the effects of other factors on blood flow and on the actions and metabolism of adenosine. For example, in brain homogenates, increasing K+ concentration from 0 to 10 mM decreased the phosphorylation of adenosine by 40% (Arch and Newsholme, 1978) . Therefore, such an effect could conceivably in crease the extracellular concentrations of adeno sine. However, increased K+ levels in CSF attenu ate the vasodilatory action of adenosine in pial ves sels (Wahl and Kuschinsky, 1977) , and extracellular recordings in brain have documented an increase in K + with seizures (Astrup et aI. , 1978) . There fore, the effects of adenosine on pial vessels during seizures may not be of primary importance. How ever, smaller «50 ILm) intracerebral vessels, which appear to play a significant role in cerebral resistance (unlike pial vessels), are generally invested by glial footplates. As suggested by Henn et al. (1972) , glial cells exert active control of extracellular K+ by acting as .. spatial buffers" for brain extracellular space. Areas either wholly or partially surrounded by glial cells, such as the perivascular space, would be expected to have stable concentrations of K+, de spite large changes in extracellular K+. Con sequently, extracellular recording of K + may not accurately reflect intracerebral perivascular con centrations. Moreover, as noted previously, the cell wall of the glial footplate contains 5' -nucleotidase. Therefore, because of the unique glial-vascular cytoarchitecture of intraparenchymal vessels, adenosine may be higher and potassium lower in perivascular fluid than in interstitial fluid and, hence, be of greater importance in the regulation of intracerebral blood flow.
In summary, adenosine fulfills many of the criteria of a metabolic regulator of CBF: it is a po tent dilator of cerebral vessels, especially the smaller vessels, which presumably play a significant role in CVR; the brain produces adenosine under conditions where CVR is decreased; the increase in brain adenosine levels is, in general, temporally re lated to the increases in CBF and cerebral metabo-J Cereb Blood Flow Metabol, Vol. 1, No. 3, 1981 lism; the concentrations measured in brain tissue by rapid freezing techniques appear to be within the vasoactive range; and recent studies suggest a mech anistic relationship between changes in adenosine and changes in CBF. Hence, the data are consonant with the adenosine hypothesis. However, additional work is necessary to establish a definite cause and effect relationship between CBF and adenosine re lease under various physiologic conditions. H. Richard Winn, G. Rafael Rubio, and Robert M. Berne
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